Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | MALT1 | Q9UDY8 | 3/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14960698 | 0.85 | TRPV1 (0.35) | ALDH1A1LMNAHTTHSD11B1CYP2A6 | |
| SCHEMBL3418088 | 0.85 | DHODH (0.38) | HSD11B1TRPA1CYP2A6CYP17A1CYP1A2 | |
| SCHEMBL25082888 | 0.82 | SLC16A3 (0.32) | HSD11B1TRPA1CYP17A1CYP1A2MALT1 | |
| SCHEMBL10119996 | 0.82 | KDM4E (0.47) | ALDH1A1HSD11B1TRPA1OPRL1TRPV1 | |
| SCHEMBL26387008 | 0.76 | LMNA (0.36) | ALDH1A1LMNAHTTHSD11B1TRPA1 | |
| SCHEMBL13105266 | 0.76 | CYP17A1 (0.40) | ALDH1A1LMNAHTTHSD11B1CYP17A1 | |
| SCHEMBL11983866 | 0.75 | RAB9A (0.47) | ALDH1A1LMNA | |
| SCHEMBL25008979 | 0.75 | TRPA1 (0.33) | TRPA1MALT1OPRL1TRPV1 | |
| SCHEMBL958268 | 0.75 | MALT1 (0.40) | ALDH1A1LMNAHTTTRPA1MALT1 | |
| SCHEMBL29558552 | 0.75 | TRPA1 (0.38) | ALDH1A1LMNAHTTTRPA1MALT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240067624-A1 | PROCESS FOR PREPARATION OF INSECTICIDAL ANTHRANILAMIDES | UPL LTD (IN) | 2024-02-29 | — | — | US | disclosed |
| WO-2022149098-A1 | PROCESS FOR PREPARATION OF INSECTICIDAL ANTHRANILAMIDES | UPL LIMITED (IN) | 2022-07-14 | — | — | WO | disclosed |
| WO-2008126933-A2 | PROCESS FOR PRODUCING PESTICIDAL BENZAMIDE COMPOUNDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240067624-A1 | PROCESS FOR PREPARATION OF INSECTICIDAL ANTHRANILAMIDES | ANTXR2, NAAA, AGPS | ALDH1A1 1498/4885LMNA 1013/4885HTT 4258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.